9 results
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... #DecisionAid #Orals ... #DM2 #Diabetes ... Endocrinology #Pharmacology ... #Management
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Diabetes Medication ... images/2507 #Management ... #DM2 #PatientInfo ... #SideEffects #A1c ... Reduction #Costs #Pharmacology
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Oral Hypoglycemics ... in Diabetes Management ... @AmyChung #Oral ... #Management #pharmacology ... #DM2 #DMII #Classification
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... has a smaller A1c ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2
Type 2 Diabetes - Screening, Diagnosis and Management Algorithm
Lifestyle  Modifications (Diet and Exercise) -> Start
Diagnosis and Management ... Exercise) -> Start Oral ... > Start Second Oral ... PostPrandial Insulin A1c ... Rubella) • Medications
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... There is an ORAL ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes ... #DM2 #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... semaglutide, the same medication ... have significant A1c ... #semaglutide #Diabetes ... #Pharmacology #
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... neuroexam - Oral ... Insulin dependent DM ... Diabetes regimen ... medical and surgical management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... system (RAAS) inhibitor ... hypertension, diabetes ... every 3 months during ... cardiology #oncology #pharmacology